This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
midgardfinance.com
midgardfinance.com
did:plc:6elkozr74dmgtebnjmwcre7e
Obesity Phase 3: efficacy vs tolerability.
Tirz + CagriSema: best quadrant.
Retatrutide: top efficacy, mid dropouts.
Survodutide: alone in high-dropout / mid-efficacy.
🇩🇰 $ZEAL 🇩🇰 $NOVO $NVO 🇺🇸 $LLY
#GLP1 #Obesity #BoehringerIngelheim #Survodutide #SYNCHRONIZE1
2026-06-08T12:47:58.185Z